Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma-Reference-Cited by-全球学者库

Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma

Published:2018-12-03 Issue:4 Volume:144 Page:868-876
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Huang Feng-Qing¹,Li Jing²,Jiang Lin³,Wang Feng-Xiang¹,Alolga Raphael N.¹,Wang Ma-Jie²,Min Wen-Jian¹,Ma Gaoxiang²,Zhao Yi-Jing¹,Wang Shi-Lei¹,Yu Yuan⁴,Chen Xiang⁵,Zhu Danxia⁶,Zhu Jun⁷,Wang Guangzhou⁸,Xia Tiansong⁹,Sang Jian-Feng¹⁰,Lai Mao-De¹,Li Ping¹,Zhu Wei¹¹¹²,Qi Lian-Wen¹^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing Jiangsu China

2. The Clinical Metabolomics Center; China Pharmaceutical University; Nanjing Jiangsu China

3. Department of Endocrinology and Metabolism; First Affiliated Hospital of Nanjing Medical University; Nanjing Jiangsu China

4. Department of Endocrinology; Shanghai East Hospital, Tongji University School of Medicine; Shanghai China

5. Department of General Surgery; The Affiliated Yixing Hospital of Jiangsu University; Yixing Jiangsu China

6. Department of Oncology; The Third Affiliated Hospital of Soochow University; Changzhou Jiangsu China

7. Department of Radiation Oncology; Jiangsu Cancer Hospital; Nanjing China

8. Clinical Lab; Northern Jiangsu People's Hospital; Yangzhou Jiangsu China

9. Department of Breast Surgery, Breast Disease Center of Jiangsu Province; First Affiliated Hospital of Nanjing Medical University; Nanjing China

10. Department of General Surgery; Nanjing Drum Tower Hospital; Nanjing Jiangsu China

11. Department of Oncology; The First Affiliated Hospital of Nanjing Medical University; Nanjing China

12. Department of Oncology; The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University; Suzhou China

Funder

National Science Fund of China for Distinguished Young Scholars

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31925/fullpdf

Reference20 articles.

1. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter;Yao;Mol Biosyst,2011

2. AACE/ACE/AME task force on thyroid nodules. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and Management of Thyroid Nodules-2016 update;Gharib;Endocr Pract,2016

3. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology;Alexander;N Engl J Med,2012

4. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

5. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis;Vaccarella;N Engl J Med,2016

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From co-delivery to synergistic anti-inflammatory effect: Studies on chitosan-stabilized Janus emulsions having chloroquine phosphate and flavopiridol in Complete Freund's Adjuvant induced arthritis rat model;International Journal of Biological Macromolecules;2024-02

2. Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma;Scientific Reports;2023-10-17

3. Significant dysregulation of lipid metabolism in patients with papillary thyroid carcinoma after thyroidectomy;Frontiers in Endocrinology;2023-10-12

4. Experimental study on changes in metabolic mechanism of papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis;Heliyon;2023-10

5. Construction and validation of a metabolism-related prognostic model for thyroid cancer;American Journal of Otolaryngology;2023-09